B Evidence Grade B Graded accuracy verified by the review judge Safe to Cite Recent

52%

52% -- physician unmet need rate for metastatic pancreatic ductal adenocarcinoma (2025-03)

2025-03  · n=101  · ZoomRx

52% of surveyed oncologists identified metastatic pancreatic ductal adenocarcinoma as the tumor type with the biggest treatment need.

Cite this stat Share How we verify
Attribution: ZoomRx View source
Lighthouse Research Team
Last verified:  ·  How we verify data →
Source verified Evidence graded
Value
52%
Unit
Percentage
Data Vintage
2025-03
Entity
metastatic pancreatic ductal adenocarcinoma
Sample Size
101
B
Strong, reliable evidence

Sourced from a well-regarded research firm or industry leader with transparent methodology and a reasonably large sample.

61/100 confidence

Single source - not yet corroborated

Extraction
95
Source Trust
60
Citation Chain
20
Independence
30
Methodology
45
Freshness
95
ZoomRx Primary Tier A
https://blog.zoomrx.com/brand-builder/asco-2025-preview-oncology-pipeline-dynamics-and-healthcare-pr… ↗
Confidence: 57/100 Vintage: 2025-03 Channel: Wayback
Source Article
ASCO 2025 Preview: Oncology Pipeline Dynamics and Healthcare Provider Priorities
ADCs & Bispecifics Lead Oncologist Excitement for Emerging Cancer Therapies Healthcare Provider Sentiment Toward Emerging Cancer Therapeutics As the oncology community prepares for American Society of Clinical Oncology's annual meeting in 2025, new research from ZoomRx reveals which therapeutic appr…
Original Research
ZoomRx · Original study ↗

ZoomRx survey of 101 oncologists in US, UK, Germany

Methodology documented
Industrymarketing
Plain Text
metastatic pancreatic ductal adenocarcinoma: 52% physician unmet need rate. Source: ZoomRx (2025-03). Via Lighthouse Intelligence -- https://lighthousedata.io/data/metastatic-pancreatic-unmet-need-2025
HTML Embed
<blockquote cite="https://lighthousedata.io/data/metastatic-pancreatic-unmet-need-2025" style="border-left:3px solid #2563eb;padding:12px 16px;margin:16px 0;font-family:system-ui,sans-serif;background:#f0f4ff;"><strong>52%</strong> -- physician unmet need rate for metastatic pancreatic ductal adenocarcinoma<br><small>Source: ZoomRx (2025-03) · <a href="https://lighthousedata.io/data/metastatic-pancreatic-unmet-need-2025" target="_blank" rel="noopener">Lighthouse Intelligence</a></small></blockquote>
Share
Share on X Share on LinkedIn

Use this data in your work

Copy the citation, embed the widget, or explore thousands more verified marketing statistics -- all free.

Copy citation Explore similar stats →